Skip to content
DataLookout
Menu

GASTROTRACKNCT07884669

Biomarker Investigation for Early Gastric Cancer Detection

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Nov 2026 to Nov 12, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Diagnostic performance of salivary and gastric juice biomarker signatures for identifying gastric and gastroesophageal junction cancer (GEC).
Timeframe: At gastroscopy

Secondary (13)

Presence of circulating tumor DNA (ctDNA) at baseline.
Longitudinal variation of ctDNA.
Association between ctDNA status and progression-free survival.
Association between ctDNA status and overall survival.
Plasma cytokine concentrations at baseline.
Show 8 moreShow less
Association between cytokine concentrations and progression occurrence.
Progression-free survival according to cytokine concentrations.
Overall survival according to cytokine concentrations.
Tumor transcriptomic profiles measured by RNA sequencing.
Tumor microenvironment characteristics measured by multiplex immunofluorescence (multi IF).
Association between microenvironment features and disease progression occurrence.
Overall survival associated with tumor microenvironment features.
Performance of an integrated multi-parametric biomarker model for prediction of survival outcomes.

Arms and interventions

Non-operable gastroesophageal cancerExperimental

Procedures: Saliva sampling, Gastric juice sampling, Blood sampling, Tumor sampling

Sites

1 site in 1 country

  • Centre Léon BérardLyon, France